PreveCeutical Medical, Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) Teams Up with Cannabis Producer to Develop Drug Delivery System

As the legal cannabis market continues to grow, new deals are creating opportunities for a range of companies and an influx of investments. PreveCeutical Medical, Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has teamed up with research institutions in Australia and gained a government permit to import cannabis for development of its drug delivery system. Cannabis for this project will be supplied by Aurora Cannabis (OTCQX: ACBFF) (TSX: ACB), a company experiencing significant production growth, including a deal for a new joint venture in Denmark. ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) is expanding its production facilities and utilizing a computer-controlled system to ensure the best growing conditions, while Aphria, Inc. (TSX: APH) (OTCQB: APHQF) has developed an expansion strategy using targeted investment and collaborations to help the company and its partners grow. And with legal recreational cannabis coming to Canada, Canopy Growth Corp. (TSX: WEED) (OTC: TWMJF) has secured a $191 million investment from Constellation Brands to support new products such as cannabis-infused soft drinks.